(Q39535046)

12 September 2017

title

HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma (English)

1 reference

12 September 2017

Qiao-Lin Zhang

1

1 reference

12 September 2017

Chun-Li Luo

2

1 reference

12 September 2017

Xiao-Hou Wu

3

1 reference

12 September 2017

Chun-Yuan Wang

4

1 reference

12 September 2017

Xin Xu

5

1 reference

12 September 2017

Yan-Yi Zhang

6

1 reference

12 September 2017

Qi Liu

7

1 reference

12 September 2017

Sha-Li Shen

8

1 reference

12 September 2017

publication date

1 October 2011

1 reference

Journal of Cellular Biochemistry

12 September 2017

published in

1 reference

12 September 2017

volume

112

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

2910-2919

1 reference

Oncogenic activity of the c-Myc protein requires dimerization with Max.

12 September 2017

cites work

1 reference

Cell cycle control in breast cancer cells

21 January 2018

1 reference

Disregulation of E-cadherin in transgenic mouse models of liver cancer

21 January 2018

1 reference

Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma

21 January 2018

1 reference

Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder

21 January 2018

1 reference

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

21 January 2018

1 reference

Uteroglobin promoter-targeted c-MYC expression in transgenic mice cause hyperplasia of Clara cells and malignant transformation of T-lymphoblasts and tubular epithelial cells.

21 January 2018

1 reference

Regulation of translation initiation by FRAP/mTOR

21 January 2018

1 reference

Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma

21 January 2018

1 reference

N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling.

21 January 2018

1 reference

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia

21 January 2018

1 reference

Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.

21 January 2018

1 reference

Nuclear PTEN levels and G2 progression in melanoma cells

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2009

1 reference

HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity

21 January 2018

1 reference

Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation

21 January 2018

1 reference

The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells

21 January 2018

1 reference

Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells

21 January 2018

1 reference

Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.

21 January 2018

1 reference

Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells

21 January 2018

1 reference

The immunoglobulin-like cell adhesion molecule hepaCAM modulates cell adhesion and motility through direct interaction with the actin cytoskeleton

21 January 2018

1 reference

Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells

21 January 2018

1 reference

Structural and functional analyses of a novel ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells

21 January 2018

1 reference

Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.

21 January 2018

1 reference

PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression

21 January 2018

1 reference

Expression and clinical significance of hepaCAM and VEGF in urothelial carcinoma

21 January 2018

1 reference

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

21 January 2018

1 reference

The ins and outs of MYC regulation by posttranslational mechanisms

21 January 2018

1 reference

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

21 January 2018

1 reference

Expression of hepaCAM and its effect on proliferation of tumor cells in renal cell carcinoma.

21 January 2018

1 reference

HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.23207

1 reference

12 September 2017

1 reference